Found 402 clinical trials
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
with moderate to severe UC. Dose selection for further clinical development will be based on the multiple efficacy, safety and PK parameters. The study consists of 4 parallel arms (3 dose groups
- 34 views
- 07 Apr, 2023
- 6 locations
Ulcerative Colitis Research Study
Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication. Must be receiving treatment for Ulcerative Colitis
- 954 views
- 07 Nov, 2020
- 1 location
A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
with moderately to severely active Ulcerative Colitis (UC) with an eosinophilic phenotype. Screening period: 2 to 4 weeks Treatment period: 52-week investigational medicinal
- 0 views
- 12 May, 2023
- 7 locations
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
This Phase 2 study is designed to evaluate the efficacy and safety of itacitinib in men and women with moderate to severe UC. The study consists of Part A and Part B, which consist of 12 weeks of
- 78 views
- 10 May, 2022
- 5 locations
MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS
ULCERATIVE COLITIS IS AN INFLAMMATORY BOWEL DISEASE THAT CAUSES LONG-LASTING INFLAMMATION AND ULCERS (SORES) IN YOUR DIGESTIVE TRACT.
- 99 views
- 23 Nov, 2020
- 1 location
Have been diagnosed with moderate to severe Ulcerative Colitis?
Have been diagnosed with moderate to severe Ulcerative Colitis?
- 72 views
- 08 Nov, 2020
- 1 location
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
- 106 views
- 08 Nov, 2020
- 1 location